Boronic Acid-based Enzyme Inhibitors: A Review of Recent Progress

Author(s): H. Fu, H. Fang, Jie Sun, H. Wang, A. Liu, J. Sun, Z. Wu.

Journal Name:Current Medicinal Chemistry

Volume 21 , Issue 28 , 2014

  Journal Home
Translate in Chinese

Abstract:

Since Bortezomib was approved by US FDA as the first drug to treat multiple myeloma, various boronic acid compounds have been developed as enzyme inhibitors. This paper reviewed the progress of boronic acid-based inhibitors against enzymes including proteasome, serine protease, HDACs and other enzymes in the past decade.

Keywords: Boronic acid, bortezomib, enzyme inhibitor, HDACs, proteasome inhibitor, serine protease.

Rights & PermissionsPrintExport

Article Details

VOLUME: 21
ISSUE: 28
Year: 2014
Page: [3271 - 3280]
Pages: 10
DOI: 10.2174/0929867321666140601200803
Price: $58